Marianne Byrne

Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study

Behzad Hajarizadeh, Jason Grebely, Marianne Byrne et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 95 citations · Full text

Preventive Medicine, Treatment And Prevention, Viral Hepatitis +9

Can a new formulation of opiate agonist treatment alter stigma?: Place, time and things in the experience of extended-release buprenorphine depot

Carla Treloar, Kari Lancaster, Sandra Gendera et al. · International Journal of Drug Policy · 2022 · 50 citations · Full text

Opioid Epidemic, Substance Abuse, New Formulation +11

Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence

Michael Farrell, Jeyran Shahbazi, Marianne Byrne et al. · International Journal of Drug Policy · 2021 · 48 citations · Full text

A ‘one-stop-shop’ point-of-care hepatitis C RNA testing intervention to enhance treatment uptake in a reception prison: The PIVOT study

Yumi Sheehan, Evan B. Cunningham, Amanda Cochrane et al. · Journal of Hepatology · 2023 · 47 citations

Reception Prison, Hepatology, Hepatitis C +7

A national programme to scale-up decentralised hepatitis C point-of-care testing and treatment in Australia

Jason Grebely, Corey Markus, Louise Causer et al. · ˜The œLancet. Gastroenterology & hepatology · 2023 · 33 citations

Primary Care, Point-of-care Testing, Hepatology +8